Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.
Also called NCT04922281
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT04922281
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04922281. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-28 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
- Acronym
- ICMREDUCE-AF
- Condition
- Atrial Fibrillation
- Condition
- Cardiovascular Diseases
- Condition
- Heart Diseases
- Condition
- Arrhythmias, Cardiac
- Condition
- Pathologic Processes
- Intervention (Device)
- Insertable Cardiac Monitor or external non-invasive LT-ECG patch
- Lead sponsor
- University of Rochester
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct04922281- Content hash
2015bec3eed04da66558d0c15e1c02ea930bb663af7bee537e90ae8debe77e21